[F-18]DPA-714
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [F-18]DPA-714, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714. [Phase 1]